CVI
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
CVI.00383-07v1
15/2/392    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhuang, D.
Right arrow Articles by Wheat, L. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhuang, D.
Right arrow Articles by Wheat, L. J.

 Previous Article  |  Next Article 

Clinical and Vaccine Immunology, February 2008, p. 392-393, Vol. 15, No. 2
1071-412X/08/$08.00+0     doi:10.1128/CVI.00383-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Cryptococcal Glucoxylomannan Does Not Exhibit Cross-Reactivity in the MVista Histoplasma Antigen Enzyme Immunoassay{triangledown}

David Zhuang,1 Chadi Hage,2 Magdia De Jesus,3 Emily Hackett,1 Michelle Durkin,1 Thomas E. Davis,4 Arturo Casadevall,3 and L. Joseph Wheat1*

MiraVista Diagnostics, Indianapolis, Indiana 46241,1 Indiana University School of Medicine, Department of Pulmonary Medicine, Roudebush Veterans' Administration Hospital, Indianapolis, Indiana 46202,2 Albert Einstein College of Medicine, Bronx, New York 10461,3 Indiana University School of Medicine, Department of Pathology, Wishard Memorial Hospital, Indianapolis, Indiana 462024

Received 24 September 2007/ Returned for modification 10 November 2007/ Accepted 29 November 2007

The potential for cross-reaction between Cryptococcus neoformans and Histoplasma capsulatum in antigen assays was evaluated. We tested patient samples, spleens from infected mice, and purified polysaccharides in the MVista Histoplasma antigen enzyme immunoassay and cryptococcal antigen latex agglutination system for cross-reactivity, and none was observed.

* Corresponding author. Mailing address: MiraVista Diagnostics, 4444 Decatur Blvd., Suite 300, Indianapolis, IN 46241. Phone: (317) 856-2681. Fax: (317) 856-3685. E-mail: jwheat{at}miravistalabs.com

{triangledown} Published ahead of print on 12 December 2007.

Clinical and Vaccine Immunology, February 2008, p. 392-393, Vol. 15, No. 2
1071-412X/08/$08.00+0     doi:10.1128/CVI.00383-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.





Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev. Infect. Immun.
J. Clin. Microbiol. J. Virol. ALL ASM JOURNALS

Copyright © 2008 by the American Society for Microbiology. All rights reserved.